Dexmedetomidine inhibits inflammation and angiogenesis and alleviates esophageal cancer progression through ITGA6/PI3K/AKT pathway: Dexmedetomidine inhibits esophageal cancer progression. (2026). Indian Journal of Experimental Biology (IJEB), 64(01), 15-32. https://doi.org/10.56042/ijeb.v64i01.22881